Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants

BACKGROUND: The benefit to risk ratio of the treatment with erythropoietin (EPO) as a means of limiting the number of transfusions in very preterm infants during hospitalization, seems to be modest since the adoption of restrictive transfusion criteria and of policy limiting phlebotomy losses. We th...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Pediatr
Autori principali: Becquet, Odile, Guyot, Delphine, Kuo, Philippe, Pawlotsky, Françoise, Besnard, Marianne, Papouin, Micheline, Lapillonne, Alexandre
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2013
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4231464/
https://ncbi.nlm.nih.gov/pubmed/24165292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2431-13-176
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi